Xortx TherapeuticsXRTX
13F holders, Q1 2026 (March 31)2holders
$0.41avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding Xortx Therapeutics Inc. (XRTX) in their 13F filings. The largest holders were Kingsview Wealth Management, LLC ($6K) and Clearstead Advisors, LLC ($92).
- Company
- Xortx Therapeutics Inc.
- CUSIP
- 98420Q405
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $6K |
| Exits | 0 | $0 |
Ownership 2 holders
| Kingsview Wealth Management, LLC | 0.00% | New | 15,000 | $6K |
| Clearstead Advisors, LLC | 0.00% | New | 277 | $92 |
"% of holder's portfolio" is XRTX's weight in each manager's 13F, not the share of Xortx Therapeutics Inc. the manager owns.